繁体中文
设为首页
加入收藏
当前位置:药品说明书与价格首页 >> 综合药讯 >> Hylenex(注射用重组人透明质酸酶)

Hylenex(注射用重组人透明质酸酶)

2010-12-21 18:56:04  作者:佚名  来源:中国新特药网天津分站  浏览次数:695  文字大小:【】【】【
简介: FDA批准重组人类透明质酸酶注射剂(Recombinant Human Hyaluronidase Injection,商品名Hylenex)作为其他注射药物的辅助药物(促进吸收和扩散),用于皮下注射以及皮下尿路造影术中促进不透射线物质的 ...

FDA批准重组人类透明质酸酶注射剂(Recombinant Human Hyaluronidase Injection,商品名Hylenex)作为其他注射药物的辅助药物(促进吸收和扩散),用于皮下注射以及皮下尿路造影术中促进不透射线物质的吸收。


Pharmaceutical Liability News: Baxter notifies FDA of HYLENEX recombinant recall

Deerfield, IL—Baxter International Inc., in cooperation with the U.S. Food and Drug Administration (FDA), announced the voluntary recall of all lots of HYLENEX recombinant (hyaluronidase human injection). The FDA announced the recall, which was issued in conjunction with the product’s NDA-holder, Halozyme Therapeutics, on Monday, May 17, 2010.

Baxter International and Halozyme Therapeutics recalled the drug after routine stability tests revealed the presence of particulate matter in a limited number of HYLENEX vials. The particles found in these lots were identified as glass.

Baxter reported there are approximately 3,500 vials in the market place. The company will be contacting consumers to inform them of the recall and advise them to return the defective product.

The HYLENEX recombinant “is a tissue permeability modifier indicated as an adjuvant in subcutaneous fluid administration for achieving hydration; to increase the dispersion and absorption of other injected drugs; and in subcutaneous urography for improving resorption of radiopaque agents.”

Though Baxter has received no reports of adverse medical episodes in association with the product, the recall was issued as a safety precaution.

Baxter and Halozyme are working together to probe what might have caused the problem. According to the FDA press release, “Baxter and Halozyme are committed to quickly and appropriately addressing the situation.”

责任编辑:admin


相关文章
重组透明质酸酶人用注射剂Hylenex(Recombinant Human Hyaluronidase Injection)
 

最新文章

更多

· 无水酒精注射液(DEHYDR...
· DEHYDRATED ALCOHOL(无...
· 除铁能注射剂DESFERAL(D...
· ALBUMINAR IV SOLUTION(...
· Dantrium Intravenous I...
· Bunavail(盐酸丁丙诺啡...
· Dyloject(diclofenac so...
· THAM SOLUTION(trometha...
· THAM Injection SET(Tr...
· 首个基因新药Glybera注射...

推荐文章

更多

· 无水酒精注射液(DEHYDR...
· DEHYDRATED ALCOHOL(无...
· 除铁能注射剂DESFERAL(D...
· ALBUMINAR IV SOLUTION(...
· Dantrium Intravenous I...
· Bunavail(盐酸丁丙诺啡...
· Dyloject(diclofenac so...
· THAM SOLUTION(trometha...
· THAM Injection SET(Tr...
· 首个基因新药Glybera注射...

热点文章

更多

· 除铁能注射剂DESFERAL(D...
· DEHYDRATED ALCOHOL(无...
· 无水酒精注射液(DEHYDR...